Description: 
Link to upcoming buprenorphine training events, both DATA and non-DATA qualifying.
Source: 
Substance Abuse and Mental Health Services Administration (SAMHSA)
field_vote: 
Description: 
This page links to the full text, summary, and physician waiver requirements under DATA 2000.
Source: 
Substance Abuse and Mental Health Services Administration (SAMHSA)
field_vote: 
Description: 
This form is for physicians to notify the DEA (through the Substance Abuse and Mental Health Services Administration) of their intent to use Schedule III, IV, or V drugs for treatment of opioid dependent patients.
Source: 
The National Alliance of Advocates for Buprenorphine Treatment (NAABT)
field_vote: 
Description: 
This PDF Document contains the Clinical Opioid Withdrawal Scale (COWS), a common instrument used to assess a patient's opioid withdrawal severity.
Source: 
California Society of Addiction Medicine (CSAM)
field_vote: 
Description: 
This publication discusses the medical co-management of hepatitis infection and opioid abuse.
Source: 
Center for Substance Abuse Treatment (CSAT)
field_vote: 
Description: 
This CME course instructs physicians on some subtleties of buprenorphine treatment that can minimize the risk of the patient being harmed either by an adverse drug effect or by relapsing to opioid abuse.
Source: 
Clinical Tools, Inc.
field_vote: 

Pages

Subscribe to Becoming waivered